{"name":"Lumira Capital","permalink":"lumira-capital","crunchbase_url":"http://www.crunchbase.com/financial-organization/lumira-capital","homepage_url":"http://www.lumiracapital.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"416-213-4223","description":"Venture Capital Firm","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":"","alias_list":"","created_at":"Tue May 10 03:19:58 UTC 2011","updated_at":"Tue May 29 11:03:16 UTC 2012","overview":"<p>Built on a foundation that leverages over 20 years of North American venture capital experience, the Lumira Capital team has substantial experience helping to build transformational health and life science companies. </p>\n\n<p>Our goal is to make investments in market leading companies and work in partnership with those companies to develop and implement strategies to build significant businesses that in turn allow us to generate profitable exits that maximize returns within a reasonable time frame. </p>\n\n<p>As partners in our businesses we are committed to the success of our portfolio companies. We roll up our sleeves and work side by side with our entrepreneurs, their management teams and our syndication partners â€“ leveraging our internal resources, knowledge networks, deep industry expertise and relationships, as well as our operational and leadership experience to help the businesses achieve their full potential. </p>","image":{"available_sizes":[[[150,53],"assets/images/resized/0013/3918/133918v1-max-150x150.jpg"],[[228,81],"assets/images/resized/0013/3918/133918v1-max-250x250.jpg"],[[228,81],"assets/images/resized/0013/3918/133918v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"141 Adelaide Street West, Suite 770","address2":"","zip_code":"M5H 3L5","city":"Toronto, ON","state_code":null,"country_code":"CAN","latitude":null,"longitude":null},{"description":"","address1":"303 Wyman St., Suite 300","address2":"","zip_code":"02451-1208","city":"Boston","state_code":"MA","country_code":"USA","latitude":null,"longitude":null},{"description":"","address1":"3400 De Maisonneuve Ouest, Suite 1050","address2":"","zip_code":"H3Z 3B8","city":"Montreal, QC","state_code":null,"country_code":"CAN","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.bizjournals.com/sanjose/news/2011/05/09/u-systems-raises-65m-new-funding.html","source_description":"U-Systems raises $6.5M new funding","raised_amount":6500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":9,"company":{"name":"U-Systems","permalink":"u-systems","image":{"available_sizes":[[[150,51],"assets/images/resized/0013/3912/133912v1-max-150x150.jpg"],[[223,76],"assets/images/resized/0013/3912/133912v1-max-250x250.jpg"],[[223,76],"assets/images/resized/0013/3912/133912v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.argostherapeutics.com/news/2012/news_20120424_argosfinancing-FastTrackDesignation_Final.html","source_description":"Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":24,"company":{"name":"Argos Therapeutics","permalink":"argos-therapeutics","image":{"available_sizes":[[[150,52],"assets/images/resized/0014/7029/147029v1-max-150x150.png"],[[167,58],"assets/images/resized/0014/7029/147029v1-max-250x250.png"],[[167,58],"assets/images/resized/0014/7029/147029v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.businesswire.com/news/edmontonjournal/20121025005392/en/Thrasos-Secures-35-Million-Fund-THR-184-Phase","source_description":"Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":25,"company":{"name":"Thrasos","permalink":"thrasos","image":{"available_sizes":[[[150,56],"assets/images/resized/0021/7327/217327v1-max-150x150.jpg"],[[250,94],"assets/images/resized/0021/7327/217327v1-max-250x250.jpg"],[[252,95],"assets/images/resized/0021/7327/217327v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[{"description":"Amgen to Acquire Privately Held KAI Pharmaceuticals","stoned_year":2012,"stoned_month":4,"stoned_day":10,"source_url":"http://www.prnewswire.com/news-releases/amgen-to-acquire-privately-held-kai-pharmaceuticals-146796445.html","source_text":null,"source_description":"Amgen to Acquire Privately Held KAI Pharmaceuticals","stoneable_type":"FinancialOrg","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Lumira Capital","permalink":"lumira-capital"}}],"providerships":[],"funds":[{"name":"Lumira Capital ll","funded_year":2012,"funded_month":3,"funded_day":26,"raised_amount":100000000,"raised_currency_code":"USD","source_url":"http://www.newswire.ca/en/story/944017/teralys-capital-invests-in-two-new-lumira-capital-life-sciences-funds","source_description":"Teralys Capital invests in two new Lumira Capital life sciences funds"},{"name":"Merck Lumira Biosciences Fund","funded_year":2012,"funded_month":3,"funded_day":26,"raised_amount":50000000,"raised_currency_code":"USD","source_url":"http://www.newswire.ca/en/story/944017/teralys-capital-invests-in-two-new-lumira-capital-life-sciences-funds","source_description":"Teralys Capital invests in two new Lumira Capital life sciences funds"}],"video_embeds":[],"external_links":[]}